P.673 Results from a 12-month open-label safety study of lumateperone (ITI-007) in patients with stable symptoms of schizophrenia

Autor:	C.U. Correll, K.E. Vanover, S. Durgam, M. Weingart, R. Davis, A. Satlin
Rok vydání:	2019
Předmět:	Pharmacology Psychiatry and Mental health Neurology Pharmacology (medical) Neurology (clinical) Biological Psychiatry
Zdroj:	European Neuropsychopharmacology. 29:S455-S456
ISSN:	0924-977X
DOI:	10.1016/j.euroneuro.2019.09.644
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::23306f234c6582d201de934a2b55c22f https://doi.org/10.1016/j.euroneuro.2019.09.644 Zobrazit plný text záznamu Full Text from ScienceDirect